Related content

Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway:a nationwide prescription database analysis

By Furu Kari   Skurtveit Svetlana   Langhammer Arnulf   Nafstad Per  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 693-698

Springer Publishing Company

Access to resources Recommend Favorite

Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants

By Källén Bengt   Olausson Petra  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 383-388

Springer Publishing Company

Access to resources Recommend Favorite

Use of anti-asthmatic drugs during pregnancy. 2. Infant characteristics excluding congenital malformations

By Källén Bengt   Olausson Petra  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 375-381

Springer Publishing Company

Access to resources Recommend Favorite

Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications

By Källén Bengt   Otterblad Olausson Petra  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

A potential anti-asthmatic drug, CR 2039, enhances the anticonvulsive activity of some antiepileptic drugs against pentetrazol in mice

By Czuczwar S.J.   Gasior M.   Kozicka M.   Pietrasiewicz T.   Turski W.A.   Kleinrok Z.  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 233-238

Elsevier

Access to resources Recommend Favorite